Literature DB >> 21434334

[Establishment and testing practice of an integrative medical pathway for clinical management of acute myocardial infarction].

Lei Wang1, Min-zhou Zhang, Jun Zhang.   

Abstract

OBJECTIVE: To establish an integrative medical approach (IMA) for clinical management of acute myocardial infarction (AMI), and to test its efficacy.
METHODS: IMA was preliminarily established according to the guidelines and based on the Chinese medical therapy of benefiting vital qi and promoting blood circulation. And adopting non-synchronous queue design, AMI patients were assigned to the IMA group (71 cases) and the non-IMA group (70 cases), they were managed following or didn't follow the established IMA respectively. The total hospitalization time (THT), the ICU indwelling time (ICUD) and the total medical expenditure (TME) of patients were compared between groups. Moreover, for patients received primary PCI, the time for door-to-balloon (DTB) was compared in addition.
RESULTS: Comparisons between groups showed that THT in the IMA group was shorter than that in the non-IMA group (9.80 +/- 5.62 days vs. 12.01 +/- 7. 35 days , P < 0.05); but the difference of TME between groups was insignificant. For those received PCT, the DTB in the IMA group was shorter than that in the non-IMA group in terms of DTB time (82.56 +/- 17.36 min vs. 119.19 +/- 30.88 min, P < 0.01), THT (9.69 +/- 5.59 vs. 13.34 +/- 7.49 days, P < 0.01) and TME.
CONCLUSIONS: Practicing IMA for AMI, which was established based on Chinese medical therapy of benefiting vital qi and promoting blood circulation, could shorten the hospitalization time of patients, reduce the DTB time and TME in patients receiving primary PCI; fully displays its significance in hospital administration and quality control on AMI.

Entities:  

Mesh:

Year:  2011        PMID: 21434334

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  1 in total

1.  Clinical pathways based on integrative medicine in chinese hospitals improve treatment outcomes for patients with acute myocardial infarction: a multicentre, nonrandomized historically controlled trial.

Authors:  Lei Wang; Minzhou Zhang; Liheng Guo; Jianyong Qi; Haiming Luo; Hankang He; Xiaolong Wang; Haiyu Yang; Yang Wu; Canming Miu; Xiaohu Chen; Jiashin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-13       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.